Streetbeat News

PBLA

Panbela Therapeutics Inc.

http://www.sunbiopharma.com/

CEO

Michael Cullen

Open

0.37

Mkt cap

1.8M

Volume

605

High

0.37

P/E Ratio

-0.01

52-wk high

1.11

Low

0.37

Div yield

N/A

52-wk low

0.30

Panbela Therapeutics' stock is trading higher following a recommendation from the independent Data Safety Monitoring Board to continue its study without modification.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 5:56 pm

Panbela Therapeutics announced that the Data Safety Monitoring Board (DSMB) has recommended the continuation of its ASPIRE registration clinical trial without any modifications. This decision follows the second independent safety review of the trial, which is a positive development for the company's ongoing research.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 1:16 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. Mira Pharmaceuticals, TC BioPharm, Panbela Therapeutics, Estrella Immunopharma, Bio-Path Holdings, and MyMD Pharmaceuticals were among the gainers, with increases ranging from 7.14% to 9.2%. Conversely, Impel Pharmaceuticals, Avenue Therapeutics, Cyclacel Pharmaceuticals, Alaunos Therapeutics, Evoke Pharma, and Scholar Rock Holding were the losers, with their stock prices falling between 7.07% and 20.9%.

Portfolio Pulse from Benzinga Insights

November 24, 2023 | 9:31 pm

Panbela Therapeutics has reported a net loss of $7.8 million or $2.69 per share for Q3.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:26 pm

In Wednesday's after-market session, several healthcare stocks saw significant movement. Gainers included Intelligent Bio Solutions (INBS), Ontrak (OTRK), Panbela Therapeutics (PBLA), ADMA Biologics (ADMA), LifeMD (LFMD), and AcelRx Pharmaceuticals (ACRX). Losers included Assertio Holdings (ASRT), Lucy Scientific Discovery (LSDI), Omega Therapeutics (OMGA), Cutera (CUTR), Alzamend Neuro (ALZN), and Bio-Path Hldgs (BPTH). Q3 earnings reports were released for several companies.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:31 pm

The article lists the stocks that gained and lost the most in Wednesday's mid-day session. GAN Limited (NASDAQ:GAN) surged 83.9% after agreeing to be acquired by Sega Sammy Creation. Blade Air Mobility, Inc. (NASDAQ:BLDE) surged 27.3% after reporting strong Q3 FY23 revenue growth. On the other hand, DURECT Corporation (NASDAQ:DRRX) shares fell 75.5% after its Phase 2B AHFIRM trial did not achieve statistical significance. FTC Solar, Inc. (NASDAQ:FTCI) fell 62.8% after reporting Q3 earnings and announcing the departure of its CEO and CFO.

Portfolio Pulse from Lisa Levin

November 08, 2023 | 6:41 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Heart Test Laboratories, Tenon Medical, Personalis, Cyclo Therapeutics, Viracta Therapeutics, and Senti Biosciences saw their stocks rise, with Heart Test Laboratories leading the gainers with a 60.5% increase. On the other hand, Durect, Establishment Labs Hldgs, Maravai LifeSciences, Panbela Therapeutics, PaxMedica, and Ontrak saw their stocks decline, with Durect leading the losers with a 76.4% decrease.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 5:31 pm

The article discusses value stocks in the healthcare sector, highlighting five companies: Procaps Gr (PROC), Panbela Therapeutics (PBLA), Community Health Sys (CYH), Leafly Holdings (LFLY), and Ocuphire Pharma (OCUP). These stocks are considered undervalued based on their low price-to-earnings (P/E) multiples. The article also provides Q2 earnings per share for each company, showing an increase for most compared to Q1.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 2:44 pm

Several healthcare stocks experienced significant price movements during Friday's intraday session. Notable gainers included Evelo Biosciences (EVLO), Werewolf Therapeutics (HOWL), DarioHealth (DRIO), Kazia Therapeutics (KZIA), Dermata Therapeutics (DRMA), and Novo Integrated Sciences (NVOS). On the other hand, NexImmune (NEXI), Panbela Therapeutics (PBLA), Agilon Health (AGL), Virios Therapeutics (VIRI), Acurx Pharmaceuticals (ACXP), and Envoy Medical (COCH) saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 5:31 pm

The article lists the stocks that have gained and lost the most in Friday's mid-day session. Among the gainers, Benson Hill, Inc. (BHIL) shares jumped 48.1% to $0.3740, and Seres Therapeutics, Inc. (MCRB) climbed 45.9% to $1.20 after posting a narrower-than-expected quarterly loss. Among the losers, Inseego Corp (INSG) shares fell 35% to $0.3370 after reporting worse-than-expected Q3 results, and Fortinet Inc (FTNT) shares fell 16.8% to $47.92 after reporting mixed Q3 results and issuing FY23 revenue guidance below estimates.

Portfolio Pulse from Lisa Levin

November 03, 2023 | 5:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.